Skip to main content
. 2016 Feb 4;23:24. doi: 10.1186/s12929-016-0242-7

Fig. 1.

Fig. 1

Moderate correlation between human plasma soluble urokinase-type plasminogen activator (uPA) receptor (suPAR) and serum creatinine in combination of FSGS (red) and MCD (blue) clinical cases